**Title:** Major Retailers Fail to Remove Contaminated Infant Formula
**Meta Description:** Four leading retailers delayed removing contaminated ByHeart infant formula linked to a botulism outbreak, prompting FDA warnings.
**URL Slug:** retailers-fail-remove-contaminated-infant-formula
**Headline:** Major Retailers Warned for Delaying Removal of Contaminated Infant Formula Linked to Botulism Outbreak
In a concerning development, four of the nation’s largest retail chains have been criticized for their failure to swiftly remove contaminated infant formula associated with a serious botulism outbreak. The U.S. Food and Drug Administration (FDA) issued warning letters to Walmart, Target, Kroger, and Albertsons, highlighting that these companies continued to sell ByHeart infant formula for days or even weeks after a recall was announced on November 11. This outbreak has affected over 50 infants across 19 states.
The FDA’s letters, made public on December 12, emphasized the responsibility of these retailers to act promptly when notified of a product recall. According to the FDA, ByHeart formula was still available at Target locations in 20 states long after the recall was initiated. Notably, one Target store in New Hampshire sold the formula on November 16, despite an electronic block intended to prevent its sale. Additionally, in Arkansas, ByHeart formula was advertised with a discount during the same period.
Reports from state and local health officials indicated that Walmart had ByHeart formula on its shelves in 21 states from November 12 to November 26. Similarly, Albertsons and Kroger had the product available in 11 and 10 states, respectively, during the recall window.
The FDA also pointed out that these retailers did not provide evidence of corrective actions taken in response to the recall, despite multiple requests. The companies have been given 15 working days to respond to the FDA’s letters.
In response to the allegations, Walmart stated that it had blocked sales of ByHeart formula at cash registers following the recall and acted quickly to remove the product from its stores. Albertsons also confirmed that it worked closely with suppliers and regulators to ensure the removal of the affected products.
All infants affected by the outbreak have been hospitalized and treated with intravenous medication to halt the progression of the disease. The Centers for Disease Control and Prevention (CDC) has expanded the outbreak’s scope to include all infants treated for botulism after consuming ByHeart formula since its production began in 2023.
Steven Mandernach, executive director of the Association of Food and Drug Officials, expressed disappointment regarding the FDA’s delayed communication about the recall to state and local food safety officials, noting that the agency did not fully share product lists until November 14, nearly a week after the initial recall.
In light of these events, it is crucial for retailers to prioritize consumer safety and ensure swift action in response to product recalls to prevent further health risks.
**FAQ Section:**
**Q: What should consumers do if they have purchased ByHeart infant formula?**
A: Consumers who have purchased ByHeart infant formula should check for recall notices and discontinue use immediately. They should return the product to the store for a refund and consult a healthcare professional if their child shows any signs of illness.
